The Global Fund, June 2017
The story of malaria in the Greater Mekong today is one of opportunity and urgency. Incidence rates have fallen by more than half since 2012, and death rates have plummeted by 84 percent. But drug resistance now threatens a devastating setback for the region and a major shock to health security if it goes global. Read more about the Global Fund’s Regional Artemisinin-resistance Initiative. Projected to total more than US$242 million over three years, it’s the Global Fund’s largest regional grant, and the first with the defined goal of disease elimination from a specific geography.